Cargando…

SARS-CoV-2 Vaccine Responses in Individuals with Antibody Deficiency: Findings from the COV-AD Study

BACKGROUND: Vaccination prevents severe morbidity and mortality from COVID-19 in the general population. The immunogenicity and efficacy of SARS-CoV-2 vaccines in patients with antibody deficiency is poorly understood. OBJECTIVES: COVID-19 in patients with antibody deficiency (COV-AD) is a multi-sit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shields, Adrian M., Faustini, Sian E., Hill, Harriet J., Al-Taei, Saly, Tanner, Chloe, Ashford, Fiona, Workman, Sarita, Moreira, Fernando, Verma, Nisha, Wagg, Hollie, Heritage, Gail, Campton, Naomi, Stamataki, Zania, Klenerman, Paul, Thaventhiran, James E. D., Goddard, Sarah, Johnston, Sarah, Huissoon, Aarnoud, Bethune, Claire, Elcombe, Suzanne, Lowe, David M., Patel, Smita Y., Savic, Sinisa, Burns, Siobhan O., Richter, Alex G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9008380/ https://www.ncbi.nlm.nih.gov/pubmed/35420363 http://dx.doi.org/10.1007/s10875-022-01231-7

Ejemplares similares

Increased Seroprevalence and Improved Antibody Responses Following Third Primary SARS-CoV-2 Immunisation: An Update From the COV-AD Study
por: Shields, Adrian M., et al.
Publicado: (2022)

Impact of vaccination on hospitalization and mortality from COVID-19 in patients with primary and secondary immunodeficiency: The United Kingdom experience
por: Shields, Adrian M., et al.
Publicado: (2022)

Formulation of a Composite Nasal Spray Enabling Enhanced Surface Coverage and Prophylaxis of SARS‐COV‐2
por: Moakes, Richard J. A., et al.
Publicado: (2021)

T-cell abnormalities in common variable immunodeficiency: the hidden defect
por: Wong, Gabriel K, et al.
Publicado: (2016)

The liver as an immunological barrier redefined by single‐cell analysis
por: Stamataki, Zania, et al.
Publicado: (2020)

Resolution of Persistent COVID-19 After Convalescent Plasma in a Patient with B Cell Aplasia
por: McKemey, Emily, et al.
Publicado: (2021)

Correction to: Resolution of Persistent COVID-19 After Convalescent Plasma in a Patient with B Cell Aplasia
por: McKemey, Emily, et al.
Publicado: (2021)

Mycetoma Caused by Acremonium Species in a Patient with Chronic Granulomatous Disease
por: Antrobus, Richard, et al.
Publicado: (2016)

In Vitro Systems for the Study of Hepatitis C Virus Infection
por: Wilson, Garrick K., et al.
Publicado: (2012)

Sudden onset hepatitis in children
por: Kelly, Deirdre A., et al.
Publicado: (2022)

Case report: Clearance of longstanding, immune-deficiency-associated, vaccine-derived polio virus infection following remdesivir therapy for chronic SARS-CoV-2 infection
por: Bermingham, William Hywel, et al.
Publicado: (2023)

A systematic review of the clinical effectiveness of acupuncture for allergic rhinitis
por: Roberts, Jonathan, et al.
Publicado: (2008)

Rhamnolipid Nano-Micelles Inhibit SARS-CoV-2 Infection and Have No Dermal or Eye Toxic Effects in Rabbits
por: Ali, Alaa M., et al.
Publicado: (2022)

COVID-19 in patients with primary and secondary immunodeficiency: The United Kingdom experience
por: Shields, Adrian M., et al.
Publicado: (2021)

Biomarkers in Human Anaphylaxis: A Critical Appraisal of Current Evidence and Perspectives
por: Beck, Sarah C., et al.
Publicado: (2019)

Clearance of Apoptotic Cells by Tissue Epithelia: A Putative Role for Hepatocytes in Liver Efferocytosis
por: Davies, Scott P., et al.
Publicado: (2018)

Understanding COVID-19: are children the key?
por: Warner, Suz, et al.
Publicado: (2021)

Prescribing Immunoglobulin Replacement Therapy for Patients with Non-classical and Secondary Antibody Deficiency: an Analysis of the Practice of Clinical Immunologists in the UK and Republic of Ireland
por: Edgar, John David M., et al.
Publicado: (2018)

Serological responses to SARS-CoV-2 following non-hospitalised infection: clinical and ethnodemographic features associated with the magnitude of the antibody response
por: Shields, Adrian M, et al.
Publicado: (2020)

Serological responses to SARS-CoV-2 following non-hospitalised infection: clinical and ethnodemographic features associated with the magnitude of the antibody response
por: Shields, Adrian M, et al.
Publicado: (2021)

Outcomes following SARS-CoV-2 infection in patients with primary and secondary immunodeficiency in the UK
por: Shields, Adrian M, et al.
Publicado: (2022)

Aberrant X chromosome skewing and acquired clonal hematopoiesis in adult-onset common variable immunodeficiency
por: Wong, Gabriel K., et al.
Publicado: (2019)

Cross reactivity of spike glycoprotein induced antibody against Delta and Omicron variants before and after third SARS-CoV-2 vaccine dose in healthy and immunocompromised individuals
por: Faustini, Sian, et al.
Publicado: (2022)

British Society for Immunology/United Kingdom Primary Immunodeficiency Network consensus statement on managing non‐infectious complications of common variable immunodeficiency disorders
por: Bethune, C., et al.
Publicado: (2019)

Detection of antibodies to the SARS-CoV-2 spike glycoprotein in both serum and saliva enhances detection of infection
por: Faustini, Sian E., et al.
Publicado: (2020)

Rituximab Treatment in Hepatitis C Infection: An In Vitro Model to Study the Impact of B Cell Depletion on Virus Infectivity
por: Stamataki, Zania, et al.
Publicado: (2011)

Cell-in-Cell Structures in the Liver: A Tale of Four E’s
por: Davies, Scott P., et al.
Publicado: (2020)

Accelerated Loss of TCR Repertoire Diversity in Common Variable Immunodeficiency
por: Wong, Gabriel K., et al.
Publicado: (2016)

Predicting the Occurrence of Variants in RAG1 and RAG2
por: Lawless, Dylan, et al.
Publicado: (2019)

Case report: Acute liver failure in children and the human herpes virus 6-? A factor in the recent epidemic
por: Warner, Suz, et al.
Publicado: (2023)

Dominant immunosuppression of dendritic cell function by prostate-cancer-derived exosomes
por: Salimu, Josephine, et al.
Publicado: (2017)

Development of a high‐sensitivity ELISA detecting IgG, IgA and IgM antibodies to the SARS‐CoV‐2 spike glycoprotein in serum and saliva
por: Faustini, Sian E., et al.
Publicado: (2021)

Immunogenicity of single vaccination with BNT162b2 or ChAdOx1 nCoV-19 at 5–6 weeks post vaccine in participants aged 80 years or older: an exploratory analysis
por: Parry, Helen, et al.
Publicado: (2021)

SARS-CoV-2 diagnostics: Towards a more comprehensive approach to routine patient testing
por: Carter, Clive, et al.
Publicado: (2021)

Cross reactivity of serological response to SARS-CoV-2 vaccination with viral variants of concern detected by lateral flow immunoassays
por: Ebanks, Daniel, et al.
Publicado: (2021)

Severity of SARS-CoV-2 infection is associated with high numbers of alveolar mast cells and their degranulation
por: Krysko, Olga, et al.
Publicado: (2022)

Validation of a combined ELISA to detect IgG, IgA and IgM antibody responses to SARS-CoV-2 in mild or moderate non-hospitalised patients
por: Cook, A.M., et al.
Publicado: (2021)

Preferential uptake of SARS-CoV-2 by pericytes potentiates vascular damage and permeability in an organoid model of the microvasculature
por: Khan, Abdullah O, et al.
Publicado: (2022)

SARS-CoV-2 seroprevalence and asymptomatic viral carriage in healthcare workers: a cross-sectional study
por: Shields, Adrian, et al.
Publicado: (2020)

The Hyperlipidaemic Drug Fenofibrate Significantly Reduces Infection by SARS-CoV-2 in Cell Culture Models
por: Davies, Scott P., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_le4u5sv6le5dbuglfu4c1cir4v